Comparison of platelet immunity in patients with SLE and with ITP

Transfusion Science

Volumn 22, Issue 1-2, 2000, Pages 19-27

  Lazarus, Alan H ^a,b,c,d   Ellis, Janet ^a,d   Semple, John W ^a,b,c,d   Mody, Meera ^a,d   Crow, Andrew R ^a,c,d   Freedman, John ^a,b,c,d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CANADIAN BLOOD SERVICES   (Canada)

^d Toronto Platelet Immunobiology Group   (Canada)

Author keywords

Cytokines; Idiopathic thrombocytopenic purpura; Platelets; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CYTOKINE; HLA DR ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNITY; CELL CULTURE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; NORMAL HUMAN; RETICULAR FORMATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE STRUCTURE; THROMBOCYTE VOLUME; THROMBOCYTOPENIA;

ADULT; ANTIGEN-PRESENTING CELLS; BLOOD PLATELETS; CELL DIVISION; CYTOKINES; CYTOLOGICAL TECHNIQUES; HUMANS; IMMUNITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MITOGENS; PLATELET COUNT; PLATELET FUNCTION TESTS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 0347899606     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(00)00004-7     Document Type: Conference Paper

References (31)

1. Semple JW, Freedman J. Abnormal cellular immune mechanisms associated with autoimmune thrombocytopenia. Transfus Med Rev 1995;9:327-38.
2. Lazarus AH, Joy T, Crow AR. Analysis of transmembrane signalling and T cell defects associated with idiopathic thrombocytopenic purpura (ITP). Acta Paediatr (Suppl) 1998;424:21-5.
3. Boshkov L, Kelton J, Halloran PF. HLA-DR expression by platelets in acute idiopathic thrombocytopenic purpura. Br J Haematol 1992;81:552.
4. Semple JW, Milev Y, Cosgrave D, Mody M, Hornstein A, Blanchette V, Freedman J. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: Relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood 1996;87:4245-54.
5. + cells from autoimmune thrombocytopenic purpura (ATP) patients: Their implication in the clinical course of the disease. Amer J Hematol 1995;49:271-6.
6. Zeigler ZR, Rosenfield CS, Nemunaitis JJ, Besa EC, Shadduck RK. Increased macrophage colony-stimulating factor levels in immune thrombocytopenic purpura. Blood 1993;81:1251-4.
7. Abboud R, Laver J, Xu F, Weksler B, Bussel J. Serum levels of GM-CSF are elevated in patients with thrombocytopenia. Br J Haematol 1996;92:486-8.
8. Quagliatta F, Karpatkin S. Impaired lymphocyte transformation and capping in autoimmune thrombocytopenic purpura. Blood 1979;53:341-9.
9. Ware RE, Howard TA. Phenotypic and clonal analysis of T lymphocytes in childhood immune thrombocytopenic purpura. Blood 1993;82:2137-42.
10. Hymes KB, Karpatkin S. In vitro suppressor T lymphocyte dysfunction in autoimmune thrombocytopenic purpura associated with a complement fixing antibody. Br J Haematol 1990;74:330.
11. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Internat Med 1996;156:1337-44.
12. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271.
13. Saxon BR, Mody M, Blanchette VS, Freedman J. Reticulated platelet counts in the assessment of thrombocytopenic disorders. Acta Paediatr (Suppl) 1998;424:65-70.
14. Semple JW, Freedman J. Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood 1991;78:2619-25.
15. Zipris D, Lazarus AH, Crow AR, Hadzija M, Delovitch TL. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice: Evidence for thymic T cell anergy that correlates with the onset of insulitis. J Immunol 1991;146:3763-71.
16. ras activation. J Exp Med 1993;177:1221-6.
17. Nomura S, Matsuzaki T, Ozaki Y, Yamaoka M, Yoshimura C, Katsura K, Xie GL, Kagawa H, Ishida T, Fukuhara S. Clinical significance of HLA-DRB1*0410 in Japenese patients with idiopathic thrombocytopenic purpura. Blood 1998;91:3616-22.
18. Panzer S, Pabinger I, Gschwandtner ME, Mayr WR, Hütter D. Lupus anticoagulants: strong association with the major histocompatability complex class II and platelet antibodies. Br J Haematol 1997;98:342-5.
19. Houssiau FA, Lefebvre C, Vanden Berghe M, Lambert M, Devogelaer JP, Renauld JC. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995;4:393-5.
20. Hagiwara E, Gourley MF, Klinman DK. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum 1996;39:379-85.
21. Barcellini W, Rizzardi GP, Borghi MO, Nicoletti F, Fain C, Del Papa N, Meroni PL. In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity. Lupus 1996;5:139-45.
22. Lacki JK, Leszczynski P, Kelemen J, Muller W, Mackiewicz SH. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response. J Med 1997;28:99-107.
23. Lacki JK, Samborski W, Mackiewicz SH. Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins. Clin Rheumatol 1997;16:275-9.
24. Llorente L, Richaud-Patin Y, Couderc J, Alarcon-Segovia D, Ruiz-Soto R, Alcocer-Castillejos N, Alcocer-Varela J, Granados J, Bahena S, Galanaud P, Emilie D. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum 1997;8:1429-35.
25. Mogan AE, Ramdahin S, Warrington RJ. Interleukin-10 response abnormalities in systemic lupus erythematosus. Scan J Immunol 1997;46:406-12.
26. Park YB, Lee SK, Kim DS, Lee J, Lee CH, Song CH. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 1998;16:283-8.
27. Horwitz DA, Gray JD, Behrendsen SC, Kubin M, Rengaraju M, Ohtsuka K, Trinchieri G. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 1998;41:838-44.
28. Liu TF, Jones BM. Impaired production of IL-12 in system lupus erythematosus. II: IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFN-gamma and negative with disease activity in SLE. Cytokine 1998;10:148-53.
29. Liu TF, Jones BM. Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes. Cytokine 1998;10:140-7.
30. Nugent D, Wang Z, Sandborg C, Berman M. Reduced levels of IL-4 in immune mediated thrombocytopenia (ITP): Role of cytokine imbalances in autoimmune disease. Blood 1995;86 (Suppl 1):65a.
31. Alleva DG, Kaser SB, Monroy MA, Fenton MJ, Beller DI. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production Evidence for differential receptor subunit utilization associated with stimulation or inhibition. J Immunol 1997;159:2941-51.